| Literature DB >> 23271366 |
De-Yang Shen1, Shin-Hun Juang, Ping-Chung Kuo, Guan-Jhong Huang, Yu-Yi Chan, Amooru G Damu, Tian-Shung Wu.
Abstract
Phytochemical investigation of the whole plants of Andrographis echioides afforded two new 2'-oxygenated flavonoids (1) and (2), two new phenyl glycosides (3) and (4), along with 37 known structures. The structures of new compounds were elucidated by spectral analysis and chemical transformation studies. Among the isolated compounds, (1-2) and (6-19) were subjected into the examination for their iNOS inhibitory bioactivity. The structure-activity relationships of the flavonoids for their inhibition of NO production were also discussed.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23271366 PMCID: PMC3565277 DOI: 10.3390/ijms14010496
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
1H and 13C NMR data of compounds 1 and 2a in DMSO-d6.
| 1 | 2 | |||
|---|---|---|---|---|
|
| ||||
| Position | δH ( | δC | δH ( | δC |
| 2 | 159.1 | 5.70, dd (12.5, 3.0) | 74.2 | |
| 3 | 7.05, s | 111.5 | 2.64, dd (16.0, 3.0) | 43.9 |
| 3.04, dd (16.0, 12.5) | ||||
| 4 | 178.3 | 189.6 | ||
| 5 | 149.5 | 159.7 | ||
| 6 | 7.17, s | 102.1 | 6.46, d (2.5) | 97.7 |
| 7 | 151.6 | 165.4 | ||
| 8 | 130.9 | 6.32, d (2.5) | 95.9 | |
| 9 | 146.1 | 164.3 | ||
| 10 | 109.5 | 106.3 | ||
| 1′ | 117.1 | 125.0 | ||
| 2′ | 156.8 | 154.3 | ||
| 3′ | 7.04, d (8.0) | 117.1 | 6.85, d (6.5) | 115.6 |
| 4′ | 7.38, dd (8.0, 8.0) | 132.7 | 7.17, dd (6.5, 6.5) | 129.4 |
| 5′ | 6.99, ddd (8.0, 8.0, 1.6) | 119.6 | 6.84, dd (6.5, 6.5) | 119.2 |
| 6′ | 8.00, dd (8.0, 1.6) | 128.7 | 7.41, d (6.5) | 126.9 |
| 1″ | 4.60, d (7.6) | 105.5 | 4.83, d (7.5) | 101.9 |
| 2″ | 3.27–3.37, m | 73.8 | 3.26–3.43, m | 73.5 |
| 3″ | 3.27–3.37, m | 77.8 | 3.15, m | 76.4 |
| 4″ | 3.13, m | 70.4 | 3.26–3.43, m | 70.0 |
| 5″ | 3.27–3.37, m | 76.1 | 3.26–3.43, m | 77.6 |
| 6″ | 3.46, m | 61.3 | 3.26–3.43, m | 61.0 |
| 3.73, m | 3.64, m | |||
| OH-2′ | 10.75, br s | 9.80, br s | ||
| OH-8 | 9.30, br s | |||
| OCH3-7 | 3.90, s | 56.3 | 3.79, s | 55.9 |
H NMR data were measured at 400 MHz for 1, and 500MHz for 2; 13C NMR data were measured at 100 MHz for 1, and 125 MHz for 2. The assignments are based on DEPT, 1H–1H COSY, HMQC and HMBC spectra.
D2O exchangeable.
Figure 1(A) Structure of 1 and main fragments under LC/MS/MS (negative ESI); (B) LC/MS/MS spectrum.
Figure 2Selected HMBC (→) and NOESY (→) spectrum for compounds 1–5.
Figure 3(A) Structure of 2 and main fragments under LC/MS/MS (negative ESI); (B) LC/MS/MS spectrum.
Figure 4(A) Structure of 3 and main fragments under LC/MS/MS (negative ESI); (B) LC/MS/MS spectrum.
1H and 13C NMR Data for 3–5 in acetone-d6.
| Position | 3 | 4 | 5 | |||
|---|---|---|---|---|---|---|
|
| ||||||
| δC | δH mult ( | δC | δH mult ( | δC | δH mult ( | |
| 1 | 98.5 | 127.3 | 111.8 | |||
| 2 | 161.0 | 156.9 | 159.5 | |||
| 3 | 95.4 | 6.36, d (2.4) | 116.0 | 7.33, d (7.8) | 105.3 | 6.75, dd (8.4, 1.2) |
| 4 | 166.1 | 134.3 | 7.54, dd (7.8, 7.8) | 136.1 | 7.38, dd (8.4, 8.4) | |
| 5 | 96.1 | 6.14, d (2.4) | 122.0 | 7.12, dd (7.8, 7.8) | 111.2 | 6.55, dd (8.4, 1.2) |
| 6 | 165.2 | 129.9 | 7.75, d (7.8) | 163.8 | ||
| 7 | 171.7 | 193.7 | 205.0 | |||
| 8 | 49.8 | 4.23, d (16.4) | 33.8 | 2.77, s | ||
| 4.07, d (16.4) | ||||||
| 9 | 168.5 | |||||
| 1′ | 102.5 | 4.96, d (7.6) | 101.1 | 5.15, d ( 7.2) | 101.2 | 5.12, d (8.8) |
| 2′ | 74.7 | 3.60–3.40, m | 73.4 | 3.60–3.40, m | 73.6 | 3.59, dd ( 8.8, 8.8) |
| 3′ | 77.7 | 3.60–3.40, m | 77.0 | 3.60–3.40, m | 77.3 | 3.46, dd ( 8.8, 8.8) |
| 4′ | 71.2 | 3.60–3.40, m | 70.1 | 3.60–3.40, m | 70.2 | 3.54, dd (8.8, 8.8) |
| 5′ | 78.0 | 3.60–3.40, m | 77.0 | 3.60–3.40, m | 77.1 | 3.55, m |
| 6′a | 62.6 | 3.91, m | 61.4 | 3.87, m | 61.6 | 3.88, dd (12.0, 2.0) |
| 6′b | 3.69, m | 3.72, m | 3.70, dd (12.0, 5.2) | |||
| OCH3-4 | 55.9 | 3.81, s | ||||
| OCH3-7 | 52.5 | 3.88, s | ||||
| OCH3-9 | 51.1 | 3.66, s | ||||
| OH-6 | 11.4, s | 13.0, br s | ||||
Data were measured at 400MHz (1H) and 125 (13C);
Data were and in 300MHz (1H) and 75MHz (13C).
Figure 5(A) Structure of 4 and main fragments under LC/MS/MS (negative ESI); (B) LC/MS/MS spectrum.
Effects of 1–2 and 6–19 on lipopolysaccharide (LPS)-induced cell viability and NO production of RAW 264.7 macrophages ║.
| Dose (μM) | Cell viability (% of control) | NO level | NO inhibition (% of control) | IC50 (μM) | |
|---|---|---|---|---|---|
| control | (−) | 100.0 ± 3.3 | 0.2 ± 0.9 | (−) | |
| LPS | (+) | 96.9 ± 6.1 | 59.4 ± 0.8 | (−) | |
| 5.25 | 92.1 ± 4.2 | 48.1 ± 1.5 | 19.0 ± 2.5 | >42 | |
| 10.5 | 86.6 ± 1.5 | 48.1 ± 1.7 | 19.1 ± 2.9 | ||
| 21 | 83.9 ± 3.5 | 45.3 ± 1.4 | 23.7 ± 2.3 | ||
| 42 | 80.1 ± 3.7 | 42.7 ± 1.1 | 28.1 ± 1.8 | ||
|
| |||||
| 5.63 | 103.6 ± 2.3 | 49.8 ± 4.6 | 16.1 ± 7.7 | >45 | |
| 11.25 | 99.2 ± 6.8 | 46.2 ± 2.5 | 22.2 ± 4.2 | ||
| 22.5 | 99.2 ± 4.2 | 41.8 ± 1.6 | 29.6 ± 2.7 | ||
| 45 | 99.8 ± 6.0 | 39.9 ± 0.7 | 32.8 ± 1.1 | ||
|
| |||||
| 5.63 | 92.6 ± 3.0 | 45.0 ± 2.7 | 24.2 ± 4.6 | >45 | |
| 11.25 | 85.7 ± 4.6 | 46.2 ± 1.8 | 22.3 ± 3.0 | ||
| 22.5 | 84.6 ± 3.5 | 44.4 ± 2.1 | 25.2 ± 3.5 | ||
| 45 | 81.4 ± 2.1 | 43.2 ± 1.8 | 27.2 ± 3.0 | ||
|
| |||||
| 8.75 | 90.5 ± 4.0 | 45.2 ± 1.2 | 23.9 ± 2.0 | >70 | |
| 17.5 | 88.2 ± 1.7 | 44.6 ± 2.6 | 25.0 ± 4.3 | ||
| 35 | 84.9 ± 2.2 | 43.8 ± 2.1 | 26.2 ± 3.5 | ||
| 70 | 83.2 ± 5.6 | 43.5 ± 2.7 | 26.8 ± 4.6 | ||
|
| |||||
| 9.25 | 90.1 ± 7.0 | 51.7 ± 1.9 | 12.9 ± 3.2 | >74 | |
| 18.5 | 86.4 ± 6.5 | 47.2 ± 2.1 | 20.5 ± 3.6 | ||
| 37 | 82.0 ± 4.4 | 47.1 ± 1.8 | 20.7 ± 3.1 | ||
| 74 | 79.3 ± 1.7 | 42.2 ± 2.5 | 28.9 ± 4.1 | ||
|
| |||||
| 5.5 | 89.7 ± 2.7 | 42.7 ± 4.0 | 28.1 ± 6.8 | >44 | |
| 11 | 84.8 ± 1.8 | 41.1 ± 1.6 | 30.8 ± 2.7 | ||
| 22 | 83.4 ± 1.9 | 38.7 ± 3.0 | 34.8 ± 5.0 | ||
| 44 | 80.2 ± 1.7 | 38.3 ± 2.0 | 35.6 ± 3.3 | ||
|
| |||||
| 8.75 | 89.4 ± 8.3 | 41.3 ± 1.3 | 30.4 ± 2.3 | 37.6 ± 1.2 | |
| 17.5 | 84.9 ± 2.0 | 39.6 ± 1.5 | 33.3 ± 2.5 | ||
| 35 | 82.1 ± 3.7 | 30.7 ± 1.5 | 48.3 ± 2.6 | ||
| 70 | 80.1 ± 2.9 | 21.2 ± 2.7 | 64.2 ± 4.5 | ||
|
| |||||
| 5.75 | 98.9 ± 4.4 | 50.6 ± 0.6 | 14.9 ± 1.0 | >46 | |
| 11.5 | 96.2 ± 4.2 | 47.5 ± 4.0 | 20.0 ± 6.7 | ||
| 23 | 96.5 ± 4.5 | 46.7 ± 0.9 | 21.4 ± 1.4 | ||
| 46 | 93.0 ± 3.4 | 46.5 ± 1.9 | 21.7 ± 3.2 | ||
|
| |||||
| 8 | 100 ± 5.4 | 50.0 ± 2.3 | 15.8 ± 3.9 | >64 | |
| 16 | 96.5 ± 9.2 | 49.5 ± 1.0 | 16.7 ± 1.7 | ||
| 32 | 96.3 ± 4.2 | 48.0 ± 1.0 | 19.2 ± 1.6 | ||
| 64 | 94.3 ± 2.1 | 45.5 ± 2.0 | 23.4 ± 3.4 | ||
|
| |||||
| 8.5 | 98.1 ± 6.6 | 52.2 ± 1.3 | 12.1 ± 2.2 | >68 | |
| 17 | 97.7 ± 1.7 | 48.8 ± 0.7 | 17.8 ± 1.3 | ||
| 34 | 90.8 ± 2.9 | 47.9 ± 3.9 | 19.4 ± 6.6 | ||
| 68 | 90.8 ± 8.5 | 47.5 ± 1.0 | 20.1 ± 1.7 | ||
|
| |||||
| 8 | 98.9 ± 3.5 | 40.8 ± 2.7 | 31.4 ± 4.5 | 39.1 ± 1.3 | |
| 16 | 97.9 ± 3.8 | 34.3 ± 2.0 | 42.3 ± 3.4 | ||
| 32 | 94.3 ± 4.6 | 32.2 ± 1.5 | 45.8 ± 7.5 | ||
| 64 | 92.2 ± 3.2 | 23.1 ± 2.3 | 61.1 ± 3.8 | ||
|
| |||||
| 7.5 | 99.4 ± 4.3 | 45.6 ± 1.1 | 23.3 ± 1.8 | >60 | |
| 15 | 99.2 ± 2.9 | 43.0 ± 3.5 | 27.7 ± 5.9 | ||
| 30 | 98.9 ± 1.8 | 42.0 ± 4.0 | 29.3 ± 6.7 | ||
| 60 | 98.8 ± 6.9 | 41.2 ± 1.9 | 30.6 ± 3.1 | ||
|
| |||||
| 8.5 | 101.5 ± 4.3 | 56.5 ± 2.0 | 4.9 ± 3.4 | >68 | |
| 17 | 100.3 ± 1.0 | 51.7 ± 2.6 | 13.0 ± 4.4 | ||
| 34 | 99.6 ± 1.0 | 50.4 ± 4.6 | 15.1 ± 7.8 | ||
| 68 | 93.7 ± 0.9 | 44.6 ± 0.5 | 24.9 ± 0.9 | ||
|
| |||||
| 5.63 | 100.8 ± 0.8 | 52.4 ± 2.9 | 11.8 ± 4.9 | >45 | |
| 11.25 | 98.8 ± 3.5 | 51.7 ± 4.6 | 12.9 ± 7.7 | ||
| 22.5 | 97.8 ± 3.6 | 50.8 ± 3.8 | 14.5 ± 6.4 | ||
| 45 | 98.3 ± 1.9 | 46.4 ± 4.0 | 21.8 ± 6.7 | ||
|
| |||||
| 5.25 | 101.4 ± 1.2 | 53.5 ± 4.4 | 9.9 ± 7.4 | >42 | |
| 10.5 | 100.5 ± 1.8 | 52.1 ± 3.7 | 12.3 ± 6.2 | ||
| 21 | 95.6 ± 0.8 | 50.7 ± 4.5 | 14.6 ± 7.6 | ||
| 42 | 74.1 ± 6.6 | (−) | (−) | ||
|
| |||||
| 9.25 | 103.5 ± 4.8 | 52.7 ± 4.7 | 11.2 ± 8.0 | >74 | |
| 18.5 | 98.2 ± 11.3 | 47.5 ± 4.8 | 20.1 ± 8.0 | ||
| 37 | 92.9 ± 7.6 | 46.7 ± 4.0 | 21.4 ± 6.8 | ||
| 74 | 81.6 ± 6.5 | 44.4 ± 2.8 | 25.2 ± 4.7 | ||
The data were presented as mean ± S.D. for three different experiments performed in triplicate.
compared with sample of control group.
p < 0.05,
p < 0.01, and
p < 0.001 were compared with LPS-alone group.
Effects of flavones and flavanones on NO production inhibitory activity in LPS-activated mouse peritoneal macrophages.
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R1 | R2 | R3 | R4 | IC50 (μM) | R1 | R2 | R3 | IC50 (μM) | ||
| OGlc | OCH3 | OH | OH | >42 | OGlc | OCH3 | OH | >45 | ||
| OGlc | OCH3 | H | OH | >45 | OH | OCH3 | H | >74 | ||
| OH | OCH3 | H | OH | >70 | OH | OCH3 | OH | 37.6 ± 1.2 b | ||
| OGlc | OCH3 | OCH3 | H | >44 | ||||||
| OGlc | OCH3 | H | H | >46 | ||||||
| OH | OCH3 | OCH3 | H | >64 | ||||||
| OCH3 | OCH3 | OCH3 | H | 39.1 ± 1.3 | ||||||
| OH | OCH3 | OCH3 | OCH3 | >60 | ||||||
| OH | OCH3 | OCH3 | OGlc | >42 | ||||||
| OH | OCH3 | H | H | >74 | ||||||
Glc, β-d-glucopyranosyl;
Values in parentheses represent the inhibition (%) at 8 μM;
Values in parentheses represent the inhibition (%) at 8.75 μM.